Status:
COMPLETED
To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics.
Lead Sponsor:
Abbott
Collaborating Sponsors:
Dimension Research
Conditions:
Vertigo
Eligibility:
All Genders
18+ years
Brief Summary
The VERTIGO study is likely to help determine characteristics of different types of vertigo in patients presenting in the Ear Nose \& Throat (ENT) clinics with complaints of dizziness. Moreover, it wi...
Eligibility Criteria
Inclusion
- Male or female patients 18 years of age and older
- Patients with vestibular vertigo of known or unknown origin
- Patients who are willing and able to provide written informed consent
Exclusion
- Patients with any condition which, in the opinion of the investigator, makes the patient unsuitable for inclusion based on clinical judgment
- Patient with psychiatric disorders, significant neurological disorder or spinal cord damage that would make the evaluation difficult for the investigator
- Patients who are not willing to give informed consent
- Patients with a known history of hypersensitivity to betahistine
- Patients with a history of pheochromocytoma
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT02213120
Start Date
August 1 2014
End Date
March 1 2015
Last Update
May 28 2015
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Research facility ID ORG-001139
Hyderābād, Pakistan, 76090
2
Research facility ID ORG-001053
Islamabad, Pakistan, 44000
3
Research facility ID ORG-001070
Karachi, Pakistan, 75050
4
Research facility ID ORG-001051
Karachi, Pakistan, 75190